Haiyan Du

489 total citations
22 papers, 346 citations indexed

About

Haiyan Du is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haiyan Du has authored 22 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Haiyan Du's work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Interference and Gene Delivery (2 papers). Haiyan Du is often cited by papers focused on MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Interference and Gene Delivery (2 papers). Haiyan Du collaborates with scholars based in China, Czechia and United States. Haiyan Du's co-authors include Ping Liu, Junfei Wang, Shengbin Zhang, Xiaolan Wang, Jiangyong Gu, Lei Liu, Peng Qin, Guangdong Tong, Like Qu and Xiaodan Cao and has published in prestigious journals such as Life Sciences, Toxicology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Haiyan Du

22 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haiyan Du China 11 234 128 49 44 35 22 346
Chunya Lu China 10 266 1.1× 165 1.3× 39 0.8× 27 0.6× 23 0.7× 18 386
Caiguo Ye China 11 233 1.0× 142 1.1× 82 1.7× 40 0.9× 42 1.2× 16 390
Yiou Cao China 8 217 0.9× 118 0.9× 41 0.8× 54 1.2× 43 1.2× 16 317
Zahra Bahmanpour Iran 10 349 1.5× 260 2.0× 43 0.9× 35 0.8× 59 1.7× 17 524
Nanxin Zheng China 9 214 0.9× 125 1.0× 51 1.0× 12 0.3× 35 1.0× 21 351
Xinye Wang China 13 290 1.2× 121 0.9× 76 1.6× 21 0.5× 34 1.0× 45 503
Sweta Sharma Saha India 12 342 1.5× 200 1.6× 69 1.4× 24 0.5× 24 0.7× 33 517
Atefeh Seghatoleslam Iran 15 249 1.1× 65 0.5× 113 2.3× 20 0.5× 30 0.9× 45 457
Yanhong Pan China 10 201 0.9× 88 0.7× 54 1.1× 22 0.5× 109 3.1× 20 344

Countries citing papers authored by Haiyan Du

Since Specialization
Citations

This map shows the geographic impact of Haiyan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Du more than expected).

Fields of papers citing papers by Haiyan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Du. The network helps show where Haiyan Du may publish in the future.

Co-authorship network of co-authors of Haiyan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyan Du. A scholar is included among the top collaborators of Haiyan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyan Du. Haiyan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mo, Ying‐Qian, Wenxin Zhou, Meifang Li, et al.. (2025). Sorafenib induces intestinal toxicity by disturbing gut microbiota and activating the LPS/TLR4/NF-κB signaling pathway in mice. Toxicology. 517. 154220–154220. 3 indexed citations
2.
3.
4.
Sun, Lixin, Lixia Wang, Yanfeng Xi, et al.. (2023). Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer. Journal of Cancer Research and Clinical Oncology. 149(13). 11397–11410. 5 indexed citations
5.
Du, Haiyan, Yu‐Chun Chen, Chong Ma, et al.. (2023). Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer. Critical Reviews in Microbiology. 50(5). 564–580. 9 indexed citations
6.
Du, Haiyan, et al.. (2022). Anticancer Effect of Polyphyllin I in Suppressing Stem Cell‐Like Properties of Hepatocellular Carcinoma via the AKT/GSK‐3β/β‐Catenin Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 4031008–4031008. 15 indexed citations
7.
Du, Haiyan, et al.. (2021). Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGFβR Regulating TGF‐β/Smad Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 2337818–2337818. 39 indexed citations
8.
Huang, Jiahui, Chenxing Liu, Ji Lin, et al.. (2021). Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway. Life Sciences. 274. 119354–119354. 24 indexed citations
9.
Zhang, Shengbin, et al.. (2020). Potential role of microRNAs in the treatment and diagnosis of cervical cancer. Cancer Genetics. 248-249. 25–30. 73 indexed citations
10.
Liao, Xiaozhong, Wei Guo, Zhuo‐Xun Wu, et al.. (2020). Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway. Frontiers in Oncology. 10. 1732–1732. 15 indexed citations
11.
Du, Haiyan, et al.. (2020). New insights into the vancomycin‐induced nephrotoxicity using in vitro metabolomics combined with physiologically based pharmacokinetic modeling. Journal of Applied Toxicology. 40(7). 897–907. 15 indexed citations
12.
Li, Hong, Haiyan Du, Guang‐Xian Zhang, et al.. (2019). Curcumin plays a synergistic role in combination with HSV-TK/GCV in inhibiting growth of murine B16 melanoma cells and melanoma xenografts. PeerJ. 7. e7760–e7760. 12 indexed citations
13.
Du, Haiyan, et al.. (2019). <p>miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/β-catenin signaling</p>. OncoTargets and Therapy. Volume 12. 7739–7748. 35 indexed citations
14.
Chen, Xiaoping, Wen Ge Li, Haiyan Du, et al.. (2017). Extreme diversity and multiple SCCmec elements in coagulase-negative Staphylococcus found in the Clinic and Community in Beijing, China. Annals of Clinical Microbiology and Antimicrobials. 16(1). 57–57. 23 indexed citations
15.
Zhou, Zheng, Chuanke Zhao, Lixin Wang, et al.. (2015). A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition.. PubMed. 5(10). 3149–61. 35 indexed citations
16.
Qiu, Qi, Wenfang Liu, Jing Li, et al.. (2014). Pharmacokinetics of Pilsicainide Hydrochloride for Injection in Healthy Chinese Volunteers: A Randomized, Parallel-Group, Open-Label, Single-Dose Study. Clinical Therapeutics. 36(2). 255–263. 3 indexed citations
17.
Du, Haiyan, Lihou Dong, Bijun Zhao, et al.. (2012). Immunostimulatory and anti-neoplasm effects of a novel palindrome CpG oligodeoxynucleotide in mice. Acta Pharmacologica Sinica. 33(8). 1047–1054. 4 indexed citations
18.
Du, Haiyan, et al.. (2011). Effects of CS-1 on A431 cell proliferation, cell cycle, and epidermal growth factor receptor signal transduction. Acta Biochimica et Biophysica Sinica. 44(2). 136–146. 5 indexed citations
19.
Zhou, Jun, Bing Zhu, Haiyan Du, et al.. (2009). [Detection and analysis of CD271, CD133 and CD34 expressions in bone marrow cells by flow cytometry with three color fluorescence labelling].. PubMed. 17(1). 133–6. 1 indexed citations
20.
Du, Haiyan, Haifeng Song, Na Li, et al.. (2007). Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells. Acta Pharmacologica Sinica. 28(10). 1637–1644. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunya Lu Breakdown of academic impact, for papers by Caiguo Ye Breakdown of academic impact, for papers by Yiou Cao Breakdown of academic impact, for papers by Zahra Bahmanpour Breakdown of academic impact, for papers by Nanxin Zheng Breakdown of academic impact, for papers by Xinye Wang Breakdown of academic impact, for papers by Sweta Sharma Saha Breakdown of academic impact, for papers by Atefeh Seghatoleslam Breakdown of academic impact, for papers by Yanhong Pan
Rankless by CCL
2026